Literature DB >> 32259124

Daily Situation Report on Coronavirus disease (COVID-19) in Iran; March 22, 2020.

.   

Abstract

To forecast the COVID-19 epidemic trend in Iran, a set of dynamic models were created. In these models, the effect of climate and community behavior change on the reproductive number is modeled. A baseline scenario is also defined as letting the epidemic grow naturally, with no prevention/control interventions. Different levels of intervention are also defined based on the extent of population isolation. Outcomes of each scenario on the number of infected cases are computed. Modeling results shows that if effective isolation occurs in 10% of the population, 307,000 individuals will be infected with COVID-19 in Iran by May 20, 2020. For an isolation rate of 25%, started since March 10, 2020, cumulative number of deaths will be 13,450 individuals by May 20, 2020. If preventive efforts can reach a 32% effective isolation rate, a considerable decrease in the number of new cases would be expected during April and May, and the total number of deaths would decrease to 8,630. If the isolation rate increases to 40%, the total number of infected individuals is expected to be 6,030 individuals. It should be acknowledged that this model predicts the number of deaths of all COVID-19 cases, including those who will not be confirmed as COVID-19, because of non-testing or death prior to COVID-19 identification. This serious health issue requires both long-term and short-term planning and arrangements. Social distancing, and identification and isolation of suspected and confirmed cases are believed to be the most important and effective control measure, and should be strengthened soon. For further details on the methodology and results of these models, please visit: http://corona.behdasht.gov.ir/files/site1/files/Covid_Modeling_V14_26.12.98.pdf.

Entities:  

Keywords:  COVID-19; Health Information Exchange; Hospital Mortality; Pandemics; epidemiology; severe acute respiratory syndrome coronavirus 2

Year:  2020        PMID: 32259124

Source DB:  PubMed          Journal:  Arch Acad Emerg Med        ISSN: 2645-4904


  5 in total

1.  Knowledge, attitudes, practices and fear of COVID-19 among Iranians: A quick online survey.

Authors:  Ebrahim Ghaderi; Hassan Mahmoodi; Pershang Sharifi Saqqezi; Reza Ghanei Gheshlagh; Ghobad Moradi; Azad Shokri; Bakhtiar Piroozi; Amjad Mohamadi Bolbanabad; Asad Ahmadi
Journal:  Health Soc Care Community       Date:  2021-04-23

2.  Modeling and forecasting trend of COVID-19 epidemic in Iran until May 13, 2020.

Authors:  Ali Ahmadi; Yasin Fadaei; Majid Shirani; Fereydoon Rahmani
Journal:  Med J Islam Repub Iran       Date:  2020-03-31

Review 3.  Quarantine, physical distancing and social isolation measures in individuals potentially exposed to SARS-CoV-2 in community settings and health services: a scoping review.

Authors:  Tereza Brenda Clementino de Freitas; Rafaella Cristina Tavares Belo; Sabrina Mércia Dos Santos Siebra; André de Macêdo Medeiros; Teresinha Silva de Brito; Sonia Elizabeth Lopez Carrillo; Israel Junior Borges do Nascimento; Sidnei Miyoshi Sakamoto; Maiara de Moraes
Journal:  Nepal J Epidemiol       Date:  2022-06-30

4.  Assessing Iran's health system according to the COVID-19 strategic preparedness and response plan of the World Health Organization: health policy and historical implications.

Authors:  Mahboubeh Khaton Ghanbari; Masoud Behzadifar; Ahad Bakhtiari; Meysam Behzadifar; Samad Azari; Hasan Abolghasem Gorji; Saeed Shahabi; Mariano Martini; Nicola Luigi Bragazzi
Journal:  J Prev Med Hyg       Date:  2021-01-14

Review 5.  Iran COVID-19 Epidemiology Committee: A Review of Missions, Structures, Achievements, and Challenges.

Authors:  Shahin Amiri; Aliakbar Haghdoost; Ehsan Mostafavi; Hamid Sharifi; Niloofar Peykari; Ahmad Raeisi; Mohammad Assai Ardakani; Mohsen Asadi Lari; Hamid Soori; Afshin Ostovar; Babak Eshrati; Mohammad Mehdi Gouya; Mahshid Nasehi; Seyed Mahdi Tabatabaei; Manzar Amirkhani; Sana Eybpoosh
Journal:  J Res Health Sci       Date:  2021-03-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.